Invitation to second quarter and first half year 2022 presentation
Oslo, 22 August 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), will release its second quarter and first half year 2022 results on Thursday, 25 August 2022. The presentation and report will be made available on NewsWeb and the Company’s website at 07:00 CET on the same day.
Rune Nystad, CEO, and Per Arne Nygård, CFO, will host a presentation and Q&A session at 08:30 CEST on the day of results. The presentation will take place at Haakon VIIs gate 2 and will be available via webcast at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20220825_3/
After the live event, the presentation and recording will be made available under the Investor Relations section on the Company's website, https://observemedical.com/investor-relations/.
For further information, please contact:
Rune Nystad, CEO Observe Medical
Mobile: +47 916 24 683
E-mail: [email protected]
Per Arne Nygård, CFO Observe Medical
Mobile: +47 411 04 345
E-mail: [email protected]
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care, in combination with targeted M&A.
The Company is headquartered in Oslo, Norway, with additional offices in Narvik (Norway), Gothenburg (Sweden), Oulu (Finland), and Seattle (the US). In addition, Observe Medical has a direct sale organization in the Nordics and a distributor network internationally.
Further information is available at www.observemedical.com.